Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001415889-25-023590

Director sold 61,885 shares at an average $20.13 ($1,245,698)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kaye Edward M. MD Director 2025-08-29 Sale 10b5-1 −1,029 $20.00 $20,580 152,441 D: show line 1 in the form
Kaye Edward M. MD Director 2025-09-02 Sale 10b5-1 −14,860 $20.14 $299,260 137,581 D: show line 2 in the form
Kaye Edward M. MD Director 2025-09-03 Sale 10b5-1 −45,996 $20.13 $925,858 91,585 D: show line 3 in the form
Open-market sales · 61,885 sh · avg $20.13 · $1,245,698
Loading xslF345X05/form4-09032025_090950.xml…